Haemolytic uremic syndrome and gemcitabine: Jaundice is not always progression in cholangiocarcinoma

Authors

  • Laurence Crouzet Centre Eugène Marquis, Medical Oncology, Rennes, France
  • Julien Edeline Centre Eugène Marquis, Medical Oncology, Rennes, France
  • Fanny Le Du Centre Eugène Marquis, Medical Oncology, Rennes, France
  • Eveline Boucher Centre Eugène Marquis, Medical Oncology, Rennes, France
  • Odile Audrain Centre Eugène Marquis, Medical Information, Rennes, France
  • Jean-Luc Raoul Institut Paoli-Calmettes, Medical Oncology, Marseille, France

DOI:

https://doi.org/10.3109/0284186X.2012.661073

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2012-05-01

How to Cite

Crouzet, L., Edeline, J., Le Du, F., Boucher, E., Audrain, O., & Raoul, J.-L. (2012). Haemolytic uremic syndrome and gemcitabine: Jaundice is not always progression in cholangiocarcinoma. Acta Oncologica, 51(5), 687–688. https://doi.org/10.3109/0284186X.2012.661073

Issue

Vol. 51 No. 5 (2012): Acta Oncologica

Section

Articles